幹細胞爭議與各國立法規範研究

CCUR > College of Law > Department of Law & Graduate Institute of Law > journal articles > Item 987654321/34013

Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/34013

Title:	幹細胞爭議與各國立法規範研究 A Study on Stem Cells Dispute and Its Legislative Standards in Various Countries
Authors:	謝榮堂吳佩珊
Contributors:	法律系
Keywords:	幹細胞胚胎人性尊嚴生命權及生存權 Induced pluripotent stem cell Cell reprogramming Legislation of stem cells Embryo Stem cells
Date:	2009-12
Issue Date:	2016-09-06 15:08:46 (UTC+8)
Abstract:	因醫學與生物科技技術之突飛猛進，發明或發現新方式，以減輕人類以往幾乎不可能痊癒之病痛或醫療問題，如以人工受精方式孕育胎兒，再生組織工程植皮等等，而遭強烈道德性懷疑之幹細胞與複製器官研究，反對者認為科學研究操縱自然法則時，倫理及法律疑義也因應而生，最具爭議者莫過於與「人命」或「生命」界定之相關問題，人得否容許複製人？該不該以基因療法治癒病患？尤有甚者是否得以基因改良「人種」？科學家能不能為研究而摧毀胚胎？胚胎是否為「人」？甚至科學家得否為研究而製造或複製胚胎？此類問題背後，不僅屬倫理問題，更關乎病患追求生存權利，本文將就此深入探討。 Since genetic engineering and molecular biology have been developed rapidly, how to properly restrict stem cell's use has been an important law issue between ethic and saving lives: Can we consider an embryo as a human? Can we destroy an embryo in order to cure a disease? This paper introduces different kind of stem cell nowadays, including the most important breakthrough in this field -induced pluripotent stem cells -which may be the solution of the stem cell issue dilemma.We also introduce and discuss the advantages and disadvantages of the stem cell-related laws in different countries, including U.S.A, German, England, Japan and our nation. Furthermore, this paper tries to combine the cell reprogramming technology, which is a great improvement in stem cell fields, and different prospects of stem cells to propose a reasonable advice to legislation.
Relation:	軍法專刊 55:6 2009.12[民98.12] 頁106-131
Appears in Collections:	[Department of Law & Graduate Institute of Law ] journal articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	455	View/Open

View Licence

Loading...